Notably, the “CT Effector” group showed a trend of increased survival compared to the “CT Exhausted/Regulatory” group ( Figure 4A ).
← all excerpts
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens.
1
—
—